Get the Stockscreener App
6.23
3.26%
-0.21
After Hours:
6.23
Profound Medical Corp stock is traded at $6.23, with a volume of 110.85K.
It is down -3.26% in the last 24 hours and down -27.98% over the past month.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
See More
Previous Close:
$6.44
Open:
$6.46
24h Volume:
110.85K
Relative Volume:
0.62
Market Cap:
$226.11M
Revenue:
$8.98M
Net Income/Loss:
$-31.39M
P/E Ratio:
-4.6493
EPS:
-1.34
Net Cash Flow:
$-24.83M
1W Performance:
-1.42%
1M Performance:
-27.98%
6M Performance:
+12.05%
1Y Performance:
-0.64%
1-Day Range:
$6.00
$6.46
1-Week Range:
$6.00
$6.83
52-Week Range:
$3.76
$8.95
Profound Medical Corp Stock (PROF) Company Profile
Name
Profound Medical Corp
Sector
Industry
Phone
647-476-1350
Address
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
6.23 | 233.73M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Initiated | Lake Street | Buy |
| Jul-16-24 | Upgrade | Stifel | Hold → Buy |
| Nov-28-23 | Initiated | Stifel | Hold |
| Aug-04-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-21-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-15-20 | Initiated | Jefferies | Buy |
View All
Profound Medical Corp Stock (PROF) Latest News
Profound Medical Schedules Q4 and 2025 Results Call - TipRanks
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow - marketscreener.com
Profound Medical Honored with INOVAIT's 2025-2026 Mount Logan Award Recognizing the TULSA Procedure for Prostate Disease - Bitget
Profound Medical Earns INOVAIT Award, Accelerates TULSA Expansion - TipRanks
Profound Medical Honored with INOVAIT’s 2025-2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease - The Manila Times
Profound Medical Corp Receives 2025-2026 Mount Logan Award - TradingView
Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease - Yahoo Finance Singapore
(PRN) Strategic Equity Report (PRN:CA) - Stock Traders Daily
Aug Sectors: Is Profound Medical Corp in a bullish channelWatch List & Consistent Income Trade Ideas - baoquankhu1.vn
(PRN) On The My Stocks Page (PRN:CA) - Stock Traders Daily
Profound Medical Corp.'s (TSE:PRN) market cap dropped CA$42m last week; individual investors who hold 56% were hit as were institutions - simplywall.st
Profound Medical (PROF) Celebrates Milestone in Poland with 500t - GuruFocus
PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women's Health - Investing News Network
Profound Medical Marks 500th Sonalleve Procedure Milestone - TipRanks
Profound Medical Corp Celebrates 500th Sonalleve® Procedure at PRO FAMILIA - TradingView
PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health - The Manila Times
500 incision-free uterine treatments completed at Polish hospital - Stock Titan
Death Cross: What hedge funds are buying Profound Medical CorpBull Run & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Market Outlook: Is LBRDK in a consolidation phaseWeekly Stock Summary & Long-Term Investment Growth Plans - baoquankhu1.vn
Analyzing Profound Medical (NASDAQ:PROF) & Reviva Pharmaceuticals (NASDAQ:RVPH) - Defense World
Opinion: This Is the Only TSX Growth Stock to Own for the Next 3 Years - Yahoo! Finance Canada
Profound Medical (NASDAQ:PROF) Shares Down 1.3%Should You Sell? - MarketBeat
Profound Medical to Engage Investors at February Life Sciences Conferences - TipRanks
Profound Medical Corp Announces Upcoming Investor Events - TradingView
Profound Medical Announces Upcoming Investor Events - The Manila Times
How To Trade (PRN) (PRN:CA) - Stock Traders Daily
Johns Hopkins Medicine Initiates Use of Profound Medical’s TULSA-PRO System - Medical Product Outsourcing
(PROF) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Profound Medical raises US$6.45 million in Canadian private placement - MSN
Profound Medical’s TULSA-PRO marks first commercial case at Johns Hopkins - MSN
(PRN) Daily Stock Insights (PRN:CA) - Stock Traders Daily
Investors in Profound Medical (TSE:PRN) have unfortunately lost 67% over the last five years - Yahoo Finance
Profound Medical upsizes private placement to raise US$6.45 million - MSN
Profound Medical (PROF) Soars 9.5%: Is Further Upside Left in the Stock? - Yahoo Finance
Profound Medical (PROF) Introduces TULSA-PRO at Mount Sinai Hosp - GuruFocus
Long Term Trading Analysis for (PRN) (PRN:CA) - Stock Traders Daily
Profound Medical Expands TULSA-PRO Use at Mount Sinai - TipRanks
AI-guided, incision-free prostate treatment debuts at Mount Sinai - Stock Titan
Profound Medical (TSE:PRN) Hits New 1-Year HighTime to Buy? - MarketBeat
Profound Medical Exceeds 2025 TULSA-PRO Installation Target and Grows Sales Pipeline - The Globe and Mail
Objective long/short (PRN) Report (PRN:CA) - Stock Traders Daily
Profound Medical Corp Surpasses 2025 TULSA-PRO® Installation Goal - TradingView — Track All Markets
Profound Surpasses 2025 TULSA-PRO Installed Base Goal - 富途资讯
Profound Medical (PROF) Surpasses Installation Goal with TULSA-P - GuruFocus
Profound Surpasses 2025 TULSA-PRO® Installed Base Goal - Investing News Network
How Profound Medical Corp. stock performs during Fed tightening cyclesJuly 2025 Closing Moves & AI Powered Buy and Sell Recommendations - Улправда
Will Profound Medical Corp. stock reach all time highs in 2025Portfolio Gains Report & Low Risk High Win Rate Picks - Улправда
Why Profound Medical Corp. stock attracts high net worth investors2025 Buyback Activity & AI Powered Market Entry Ideas - Улправда
Why Profound Medical Corp. stock remains on buy listsOptions Play & Fast Gain Swing Trade Alerts - Улправда
Profound Medical Corp Stock (PROF) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):